We are pleased to share that Biomedical Research and Therapy (ISSN: 2198-4093) has received its first Impact Factor of 0.8 in the Journal Citation Reports™ (Clarivate) in June 2023. 

Biomedical Research and Therapy continues to be indexed in the Emerging Sources Citation Index (ESCI) within the Web of Science Core Collection. This is the first time that Clarivate has awarded Impact Factors to journals outside of the core flagship indices, SCIE and SSCI, creating greater transparency around the citedness of ESCI-indexed journals. 

Biomedical Research and Therapy seeks applications from enthusiastic researchers and scholars who can oversee and maintain the editorial direction of the journal to ensure a steady flow of engaging and thought-provoking original research publications.

Biomedical Research and Therapy (ISSN 2198-4093) was published by Springer in Global Science Journals from 2014-2015, and BioMedPress from 2016 to now. As a result of a revolution, and to improve the journal quality, the publisher decided to revise the aims and scope of Biomedical Research and Therapy.

Biomedical Research and Therapy is calling for manuscripts

Could your research be a good fit for the journal? Find out how you can benefit from publishing with us.

From Issue 4, Vol 5 (2018), BMRAT uses the reference style of VANCOUVER style. You should use reference manager software such as Endnote during the manuscript preparation.  And then format reference with Vancouver style. 

The Biomedical Research and Therapy invites proposals for special issues, especially on the following themes:

- Cells based therapies for cancers

- Targeting therapy

- Nanomedicine